Bull & Bear

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the valuation gap and capital-return inflection are too sharp to dismiss, but the auditor change and cash-flow-quality questions require one print to clear. The bull's strongest argument is mechanical: $2.48B of net cash (58% of market cap) leaves the core operating business at ~3.4× EBITDA versus AIMA at 7.8×, and the FY2025 dividend already jumped +245% YoY with a special dividend declared. The bear's strongest argument is structural quality: $211M of new supplier-finance discounting and $328M of bills-payable expansion explain most of the CFO swing from $41M to $856M, and a second Big Four resignation in five years is not a coincidence. The decisive variable for both sides is the same: the H1 2026 interim print (August 2026) on bills-payable trajectory and gross margin persistence. The durable thesis variable is whether the cash actually leaves the balance sheet — that is what would force a re-rating regardless of any one quarter.

Bull Case

Bull's reference value is around US$2.18 on a peer-anchored sum-of-parts: 6.0× EV/EBITDA on ~$650M FY2026E EBITDA (still below AIMA's 7.8×) plus $2.55B net cash, cross-checked by $0.092 normalized EPS × 13× + $0.84 net cash/share — a scenario value, not a forecast. Timeline 12–18 months, anchored to the H1 2026 interim (August 2026) and FY2026 final (March 2027). The disconfirming signals are gross margin below 16% in H1 2026, bills payable above $1.63B, and no further capital-return signal by August 2026 — any two of those three would push Bull aside.

Bear Case

Bear's downside reference is around US$0.96, built from ~$203M normalized through-cycle NI × 7× P/E = $1.42B operating value, plus $2.48B net cash discounted 35% ($1.61B) for stranded-cash + family-control + governance overhang = $3.0B equity, rounded to $2.95B — a scenario, not a forecast. Timeline 12–18 months. The cover signal is a clean Deloitte FY2026 audit (no expanded KAM on revenue or cash-flow classification) plus a contracting bills-payable book plus an explicit ≥$430M special dividend or structural buyback authorization — all three together would refute the cash-quality, governance, and stranded-cash legs simultaneously.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the math — a 3.4× EBITDA core operating business with 58% of market cap in net cash, a +245% dividend jump, and a regulatory consolidation rule that quantifiably removes ~80 small OEMs is a setup that almost never coexists at a global volume leader. The single most important tension is whether the $2.48B cash actually leaves the balance sheet, because that is the only mechanism that closes the gap to AIMA's 7.8× — the operating-leverage story is real but not load-bearing without the capital-return regime change. Bear could still be right because two Big Four resignations in five years, a 25.7% rebuild in SFC shorts, and a CFO line that reverts to 1.13× CFO/NI when you strip bills-payable and supplier-finance discounting are not noise — if the next interim shows bills payable above $1.6B and gross margin below 17%, the +245% dividend was a sweetener for a quality stock that is not actually a quality stock. The durable thesis breaker is the FY2026 capital-return regime — a second special dividend or ≥$430M structural buyback authorization confirms the variant-perception read; absence does not. The near-term evidence marker is the H1 2026 interim print (August 2026) on bills-payable trajectory and gross-margin persistence — that is when the cash-flow-quality and subsidy-peak debates resolve in one document.